{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:28:15Z","timestamp":1786588095810,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Juvenile dermatomyositis (JDM) is a complex multi-system disease that significantly impacts the health and development of affected children. Accurate and comprehensive measurement of disease activity and outcomes is essential for effective clinical management and research. Traditional unidimensional measures are insufficient for capturing the multifaceted nature of JDM, necessitating the development of specialized clinimetric tools that integrate multiple health domains and perspectives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>Over the past decades, significant advances have been made in developing and validating clinimetric assessments for JDM. Core domains such as muscle strength, skin involvement, global disease activity, and patient-reported outcomes are now routinely evaluated using established instruments like the Childhood Myositis Assessment Scale, Manual Muscle Testing, and various skin assessment tools. Composite indices, including the Juvenile Dermatomyositis Activity Index and the ACR\/EULAR Total Improvement Score, enhance sensitivity to clinical changes by integrating multidimensional data. Imaging modalities such as magnetic resonance imaging and muscle ultrasound provide objective insights into muscle inflammation and damage, while histopathology scoring offers valuable research and prognostic information. Despite these advances, challenges remain in standardizing assessments, particularly for skin disease and patient-reported symptoms like fatigue and social participation. Emerging digital health technologies and biomarker integration hold promise for improving longitudinal monitoring and precision in disease evaluation. Additionally, the treat-to-target approach in JDM underscores the need for frequent, accurate measurements to guide therapy adjustments. However, practical barriers including resource limitations and tool complexity hinder widespread clinical adoption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Considerable progress has been achieved in the development of clinimetric tools for JDM, enabling more nuanced and patient-centred disease assessment. Future efforts should prioritize the creation of disease-specific patient-reported outcome measures, streamlined and feasible assessment protocols, and the integration of biological markers and digital innovations. These advances will support precision medicine approaches and improve outcomes for children living with JDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-026-01233-4","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:55:25Z","timestamp":1780916125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Update on clinimetric assessments in juvenile dermatomyositis: conceptual foundations, current tools, and future directions"],"prefix":"10.1186","volume":"24","author":[{"given":"Charalampia","family":"Papadopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"12","key":"1233_CR1","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1017\/S0033291711000808","volume":"41","author":"R Mendel","year":"2011","unstructured":"Mendel R, Traut-Mattausch E, Jonas E, Leucht S, Kane JM, Maino K, et al. Confirmation bias: why psychiatrists stick to wrong preliminary diagnoses. Psychol Med. 2011;41(12):2651\u20139.","journal-title":"Psychol Med"},{"issue":"1","key":"1233_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1553-2712.2006.tb00990.x","volume":"13","author":"JM Pines","year":"2006","unstructured":"Pines JM. Profiles in patient safety: confirmation bias in emergency medicine. Acad Emerg Med. 2006;13(1):90\u20134.","journal-title":"Acad Emerg Med"},{"issue":"19","key":"1233_CR3","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1016\/j.cub.2018.07.052","volume":"28","author":"BC Talluri","year":"2018","unstructured":"Talluri BC, Urai AE, Tsetsos K, Usher M, Donner TH. Confirmation Bias through Selective Overweighting of Choice-Consistent Evidence. Curr Biol. 2018;28(19):3128\u2013e358.","journal-title":"Curr Biol"},{"issue":"1","key":"1233_CR4","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1038\/s41467-020-16278-6","volume":"11","author":"M Rollwage","year":"2020","unstructured":"Rollwage M, Loosen A, Hauser TU, Moran R, Dolan RJ, Fleming SM. Confidence drives a neural confirmation bias. Nat Commun. 2020;11(1):2634.","journal-title":"Nat Commun"},{"issue":"1","key":"1233_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-2496(64)90015-X","volume":"1","author":"RD Luce","year":"1964","unstructured":"Luce RD. Simultaneous conjoint measurement: A new type of fundamental measurement. J Math Psychol. 1964;1(1):1\u201327.","journal-title":"J Math Psychol"},{"issue":"6","key":"1233_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0021-9681(87)90027-0","volume":"40","author":"AR Feinstein","year":"1987","unstructured":"Feinstein AR. Clinimetric perspectives. J Chronic Dis. 1987;40(6):635\u201340.","journal-title":"J Chronic Dis"},{"issue":"5","key":"1233_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/art.40060","volume":"69","author":"LG Rider","year":"2017","unstructured":"Rider LG, Aggarwal R, Pistorio A, Bayat N, Erman B, Feldman BM, et al. 2016 American College of Rheumatology\/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 2017;69(5):911\u201323.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"1233_CR8","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/annrheumdis-2017-211401","volume":"76","author":"LG Rider","year":"2017","unstructured":"Rider LG, Aggarwal R, Pistorio A, Bayat N, Erman B, Feldman BM, et al. 2016 American College of Rheumatology\/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2017;76(5):782\u201391.","journal-title":"Ann Rheum Dis"},{"issue":"10019","key":"1233_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","volume":"387","author":"N Ruperto","year":"2016","unstructured":"Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, et al. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. Lancet. 2016;387(10019):671\u20138.","journal-title":"Lancet"},{"issue":"2","key":"1233_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/annrheumdis-2017-212141","volume":"77","author":"LJ McCann","year":"2018","unstructured":"McCann LJ, Pilkington CA, Huber AM, Ravelli A, Appelbe D, Kirkham JJ, et al. Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research. Ann Rheum Dis. 2018;77(2):241\u201350.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1233_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/acr.22142","volume":"66","author":"AB Robinson","year":"2014","unstructured":"Robinson AB, Hoeltzel MF, Wahezi DM, Becker ML, Kessler EA, Schmeling H, et al. Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis Care Res (Hoboken). 2014;66(3):404\u201310.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1233_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13075-018-1687-8","volume":"20","author":"EHP van Dijkhuizen","year":"2018","unstructured":"van Dijkhuizen EHP, De Iorio M, Wedderburn LR, Deakin CT, Jdrg. Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study. Arthritis Res Ther. 2018;20(1):180.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"1233_CR13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3899\/jrheum.200943","volume":"48","author":"J Craig","year":"2021","unstructured":"Craig J, Feldman BM, Spiegel L, Dover S. Comparing the Measurement Properties and Preferability of Patient-reported Outcome Measures in Pediatric Rheumatology: PROMIS vs CHAQ. J Rheumatol. 2021;48(7):1065\u201372.","journal-title":"J Rheumatol"},{"issue":"7","key":"1233_CR14","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/rheumatology\/key421","volume":"58","author":"S Rosina","year":"2019","unstructured":"Rosina S, Consolaro A, van Dijkhuizen P, Pistorio A, Varnier GC, Bovis F, et al. Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis. Rheumatology (Oxford). 2019;58(7):1196\u2013205.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1233_CR15","first-page":"379","volume":"43","author":"D Hortelan Antonio","year":"2025","unstructured":"Hortelan Antonio D, Carneiro BOL, Fernandes TAP, Elias AM, Pantoja de Moraes AJ, Vecchi AP, et al. Longitudinal assessment of disease activity and muscle strength in juvenile dermatomyositis: a multicentre registry study. Clin Exp Rheumatol. 2025;43(2):379\u201386.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"1233_CR16","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/acr.23491","volume":"70","author":"GC Varnier","year":"2018","unstructured":"Varnier GC, Rosina S, Ferrari C, Pistorio A, Consolaro A, Bovis F, et al. Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine Care. Arthritis Care Res (Hoboken). 2018;70(9):1312\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"1233_CR17","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1109\/TVCG.2023.3247092","volume":"29","author":"K Zhou","year":"2023","unstructured":"Zhou K, Cai R, Ma Y, Tan Q, Wang X, Li J, et al. A Video-Based Augmented Reality System for Human-in-the-Loop Muscle Strength Assessment of Juvenile Dermatomyositis. IEEE Trans Vis Comput Graph. 2023;29(5):2456\u201366.","journal-title":"IEEE Trans Vis Comput Graph"},{"issue":"7","key":"1233_CR18","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/art.42446","volume":"75","author":"JS Gofshteyn","year":"2023","unstructured":"Gofshteyn JS, Mansfield L, Spitznagle J, Balasubramanian P, Cardenas J, Miller T, et al. Association of Juvenile Dermatomyositis Disease Activity With the Expansion of Blood Memory B and T Cell Subsets Lacking Follicular Markers. Arthritis Rheumatol. 2023;75(7):1246\u201361.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"1233_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/art.20397","volume":"51","author":"RM Rennebohm","year":"2004","unstructured":"Rennebohm RM, Jones K, Huber AM, Ballinger SH, Bowyer SL, Feldman BM, et al. Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale. Arthritis Rheum. 2004;51(3):365\u201370.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1233_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20035","volume":"62","author":"LG Rider","year":"2010","unstructured":"Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken). 2010;62(4):465\u201372.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"1233_CR21","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3899\/jrheum.200543","volume":"48","author":"S Rosina","year":"2021","unstructured":"Rosina S, Varnier GC, Pistorio A, Pilkington C, Maillard S, Civino A, et al. Development and Testing of Reduced Versions of the Manual Muscle Test-8 in Juvenile Dermatomyositis. J Rheumatol. 2021;48(6):898\u2013906.","journal-title":"J Rheumatol"},{"issue":"10","key":"1233_CR22","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/acr.22867","volume":"68","author":"R Campanilho-Marques","year":"2016","unstructured":"Campanilho-Marques R, Almeida B, Deakin C, Arnold K, Gallot N, de Iorio M, et al. Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis. Arthritis Care Res (Hoboken). 2016;68(10):1514\u201321.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"1233_CR23","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/bjd.15596","volume":"177","author":"J Tiao","year":"2017","unstructured":"Tiao J, Feng R, Berger EM, Brandsema JF, Coughlin CC, Khan N, et al. Evaluation of the reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index and the Cutaneous Assessment Tool-Binary Method in juvenile dermatomyositis among paediatric dermatologists, rheumatologists and neurologists. Br J Dermatol. 2017;177(4):1086\u201392.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1233_CR24","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.jaad.2020.12.032","volume":"84","author":"A Wang","year":"2021","unstructured":"Wang A, Morgan GA, Paller AS, Pachman LM. Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis. J Am Acad Dermatol. 2021;84(6):1610\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1233_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/art.23313","volume":"59","author":"AM Huber","year":"2008","unstructured":"Huber AM, Lachenbruch PA, Dugan EM, Miller FW, Rider LG. Juvenile Dermatomyositis Disease Activity Collaborative Study G. Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats. Arthritis Rheum. 2008;59(3):352\u20136.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1233_CR26","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/jid.2011.440","volume":"132","author":"R Goreshi","year":"2012","unstructured":"Goreshi R, Okawa J, Rose M, Feng R, Lee LA, Hansen CB, et al. Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM. J Invest Dermatol. 2012;132(4):1117\u201324.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"1233_CR27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1365-2133.2008.08711.x","volume":"159","author":"RQ Klein","year":"2008","unstructured":"Klein RQ, Bangert CA, Costner M, Connolly MK, Tanikawa A, Okawa J, et al. Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis. Br J Dermatol. 2008;159(4):887\u201394.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1233_CR28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.semarthrit.2020.01.002","volume":"50","author":"S Ahmed","year":"2020","unstructured":"Ahmed S, Chen KL, Werth VP. The validity and utility of the Cutaneous Disease Area and Severity Index (CDASI) as a clinical outcome instrument in dermatomyositis: A comprehensive review. Semin Arthritis Rheum. 2020;50(3):458\u201362.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"1233_CR29","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/bjd.18223","volume":"182","author":"S Ahmed","year":"2020","unstructured":"Ahmed S, Chakka S, Concha J, Krain R, Feng R, Werth VP. Evaluating important change in cutaneous disease activity as an efficacy measure for clinical trials in dermatomyositis. Br J Dermatol. 2020;182(4):949\u201354.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1233_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12969-023-00844-5","volume":"21","author":"A Gebreamlak","year":"2023","unstructured":"Gebreamlak A, Sawicka KM, Garrett R, Goh YI, Baker KM, Feldman BM. Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM). Pediatr Rheumatol Online J. 2023;21(1):63.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"11","key":"1233_CR31","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/art.1780401109","volume":"40","author":"LG Rider","year":"1997","unstructured":"Rider LG, Feldman BM, Perez MD, Rennebohm RM, Lindsley CB, Zemel LS, et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum. 1997;40(11):1976\u201383.","journal-title":"Arthritis Rheum"},{"issue":"9631","key":"1233_CR32","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","volume":"371","author":"BM Feldman","year":"2008","unstructured":"Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet. 2008;371(9631):2201\u201312.","journal-title":"Lancet"},{"issue":"11","key":"1233_CR33","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1093\/rheumatology\/keaf335","volume":"64","author":"SR Veldkamp","year":"2025","unstructured":"Veldkamp SR, van der Griend L, Noppers E, Armbrust W, van den Berg JM, Hissink Muller PCE, et al. Advances in JDM: biomarker and MRI sensitivity, outcomes and steroid management in a Dutch national prospective cohort. Rheumatology (Oxford). 2025;64(11):5622\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"1233_CR34","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/art.40881","volume":"71","author":"J Wienke","year":"2019","unstructured":"Wienke J, Bellutti Enders F, Lim J, Mertens JS, van den Hoogen LL, Wijngaarde CA, et al. Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation. Arthritis Rheumatol. 2019;71(8):1377\u201390.","journal-title":"Arthritis Rheumatol"},{"key":"1233_CR35","doi-asserted-by":"crossref","unstructured":"Moreau TRJ, Bondet V, Veldkamp SR, Bletry D, Ramos J, Villain E, et al. IFN-alpha levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5\u2009+\u2009autoantibodies. Rheumatology (Oxford). 2026;65(1).","DOI":"10.1093\/rheumatology\/keaf549"},{"issue":"11","key":"1233_CR36","doi-asserted-by":"publisher","first-page":"e24726","DOI":"10.1002\/jcla.24726","volume":"36","author":"X Li","year":"2022","unstructured":"Li X, Liu Y, Cheng L, Huang Y, Yan S, Li H, et al. Roles of biomarkers in anti-MDA5-positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease. J Clin Lab Anal. 2022;36(11):e24726.","journal-title":"J Clin Lab Anal"},{"issue":"7","key":"1233_CR37","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3899\/jrheum.181275","volume":"47","author":"T Kishi","year":"2020","unstructured":"Kishi T, Chipman J, Evereklian M, Nghiem K, Stetler-Stevenson M, Rick ME, et al. Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis. J Rheumatol. 2020;47(7):1011\u20138.","journal-title":"J Rheumatol"},{"issue":"7","key":"1233_CR38","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/art.41639","volume":"73","author":"C Papadopoulou","year":"2021","unstructured":"Papadopoulou C, Hong Y, Krol P, Al Obaidi M, Pilkington C, Wedderburn LR, et al. The Vasculopathy of Juvenile Dermatomyositis: Endothelial Injury, Hypercoagulability, and Increased Arterial Stiffness. Arthritis Rheumatol. 2021;73(7):1253\u201366.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"1233_CR39","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(25)00233-9","volume":"24","author":"J Raaphorst","year":"2025","unstructured":"Raaphorst J, van der Kooi AJ, Mecoli CA, Weihl CC, Tas SW, Schmidt J, et al. Advances in the classification and management of idiopathic inflammatory myopathies. Lancet Neurol. 2025;24(9):776\u201388.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1233_CR40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/BOR.0000000000001043","volume":"36","author":"D Saygin","year":"2024","unstructured":"Saygin D, Albayda J. Current approach to muscle imaging in myositis. Curr Opin Rheumatol. 2024;36(6):445\u201352.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"1233_CR41","doi-asserted-by":"publisher","first-page":"101765","DOI":"10.1016\/j.berh.2022.101765","volume":"36","author":"J Albayda","year":"2022","unstructured":"Albayda J, Demonceau G, Carlier PG. Muscle imaging in myositis: MRI, US, and PET. Best Pract Res Clin Rheumatol. 2022;36(2):101765.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"1233_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/rheumatology\/keac263","volume":"62","author":"AW Walter","year":"2022","unstructured":"Walter AW, Lim J, Raaphorst J, Smithuis FF, den Harder JM, Eftimov F, et al. Ultrasound and MR muscle imaging in new onset idiopathic inflammatory myopathies at diagnosis and after treatment: a comparative pilot study. Rheumatology (Oxford). 2022;62(1):300\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"1233_CR43","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/1529-0131(200008)43:8<1866::AID-ANR24>3.0.CO;2-6","volume":"43","author":"AB Kimball","year":"2000","unstructured":"Kimball AB, Summers RM, Turner M, Dugan EM, Hicks J, Miller FW, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. Arthritis Rheum. 2000;43(8):1866\u201373.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1233_CR44","doi-asserted-by":"publisher","first-page":"W153","DOI":"10.2214\/AJR.10.5337","volume":"197","author":"PE Ladd","year":"2011","unstructured":"Ladd PE, Emery KH, Salisbury SR, Laor T, Lovell DJ, Bove KE. Juvenile dermatomyositis: correlation of MRI at presentation with clinical outcome. AJR Am J Roentgenol. 2011;197(1):W153\u20138.","journal-title":"AJR Am J Roentgenol"},{"issue":"80","key":"1233_CR45","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.15557\/JoU.2020.0007","volume":"20","author":"I Sudol-Szopinska","year":"2020","unstructured":"Sudol-Szopinska I, Jacques T, Gietka P, Cotten A. Imaging in dermatomyositis in adults and children. J Ultrason. 2020;20(80):e36\u201342.","journal-title":"J Ultrason"},{"issue":"SI","key":"1233_CR46","doi-asserted-by":"publisher","first-page":"SI48","DOI":"10.1093\/rheumatology\/keab833","volume":"61","author":"G Mamyrova","year":"2022","unstructured":"Mamyrova G, McBride E, Yao L, Shrader JA, Jain M, Yao J, et al. Preliminary validation of muscle ultrasound in juvenile dermatomyositis (JDM). Rheumatology (Oxford). 2022;61(SI):SI48\u201355.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1233_CR47","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/annrheumdis-2013-203396","volume":"74","author":"H Varsani","year":"2015","unstructured":"Varsani H, Charman SC, Li CK, Marie SK, Amato AA, Banwell B, et al. Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. Ann Rheum Dis. 2015;74(1):204\u201310.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1233_CR48","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/art.39753","volume":"68","author":"CT Deakin","year":"2016","unstructured":"Deakin CT, Yasin SA, Simou S, Arnold KA, Tansley SL, Betteridge ZE, et al. Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis. Arthritis Rheumatol. 2016;68(11):2806\u201316.","journal-title":"Arthritis Rheumatol"},{"key":"1233_CR49","doi-asserted-by":"publisher","first-page":"152649","DOI":"10.1016\/j.semarthrit.2025.152649","volume":"71","author":"K Ardalan","year":"2025","unstructured":"Ardalan K, Marques MC, Cella D, Curran ML, Gray EL, Lee J, et al. Psychometric properties of patient-reported outcomes measurement information system (PROMIS) fixed short forms in Juvenile Myositis. Semin Arthritis Rheum. 2025;71:152649.","journal-title":"Semin Arthritis Rheum"},{"key":"1233_CR50","doi-asserted-by":"crossref","unstructured":"Austenfeld EM, Sabbagh SE, Liegl M, Yan K, Do V, Fuller J, et al. PROMIS displays strong construct validity in pediatric and adult patients with idiopathic inflammatory myopathies. Rheumatology (Oxford). 2025.","DOI":"10.1093\/rheumatology\/keaf502"},{"issue":"2","key":"1233_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/acr.24760","volume":"75","author":"RN Patel","year":"2023","unstructured":"Patel RN, Esparza VG, Lai JS, Gray EL, Reeve BB, Chang RW, et al. Comparison of Patient-Reported Outcomes Measurement Information System Computerized Adaptive Testing Versus Fixed Short Forms in Juvenile Myositis. Arthritis Care Res (Hoboken). 2023;75(2):381\u201390.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"1233_CR52","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/BOR.0000000000000816","volume":"33","author":"H Kim","year":"2021","unstructured":"Kim H. Updates on interferon in juvenile dermatomyositis: pathogenesis and therapy. Curr Opin Rheumatol. 2021;33(5):371\u20137.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"1233_CR53","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13075-021-02578-9","volume":"23","author":"J Liang","year":"2021","unstructured":"Liang J, Cao H, Liu Y, Ye B, Sun Y, Ke Y, et al. The lungs were on fire: a pilot study of (18)F-FDG PET\/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease. Arthritis Res Ther. 2021;23(1):198.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"1233_CR54","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/rheumatology\/kep302","volume":"48","author":"H Sanner","year":"2009","unstructured":"Sanner H, Gran JT, Sjaastad I, Flato B. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset. Rheumatology (Oxford). 2009;48(12):1541\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1233_CR55","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/acr.23338","volume":"70","author":"Z Barth","year":"2018","unstructured":"Barth Z, Witczak BN, Flato B, Koller A, Sjaastad I, Sanner H. Assessment of Microvascular Abnormalities by Nailfold Capillaroscopy in Juvenile Dermatomyositis After Medium- to Long-Term Followup. Arthritis Care Res (Hoboken). 2018;70(5):768\u201376.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"1233_CR56","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","volume":"72","author":"D Lazarevic","year":"2013","unstructured":"Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C, et al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis. 2013;72(5):686\u201393.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1233_CR57","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1002\/art.39200","volume":"67","author":"B Almeida","year":"2015","unstructured":"Almeida B, Campanilho-Marques R, Arnold K, Pilkington CA, Wedderburn LR, Nistala K, et al. Analysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is Underestimated. Arthritis Rheumatol. 2015;67(9):2495\u2013502.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"1233_CR58","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/rheumatology\/keu146","volume":"53","author":"H Sanner","year":"2014","unstructured":"Sanner H, Sjaastad I, Flato B. Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool. Rheumatology (Oxford). 2014;53(9):1578\u201385.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1233_CR59","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1093\/rheumatology\/kead111","volume":"62","author":"H Kim","year":"2023","unstructured":"Kim H, Saygin D, Douglas C, Wilkerson J, Erman B, Pistorio A, et al. Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profiles. Rheumatology (Oxford). 2023;62(11):3680\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1233_CR60","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/rheumatology\/kex226","volume":"56","author":"LG Rider","year":"2017","unstructured":"Rider LG, Ruperto N, Pistorio A, Erman B, Bayat N, Lachenbruch PA, et al. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects. Rheumatology (Oxford). 2017;56(11):1884\u201393.","journal-title":"Rheumatology (Oxford)"},{"key":"1233_CR61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41927-019-0088-1","volume":"3","author":"A Oldroyd","year":"2019","unstructured":"Oldroyd A, Little MA, Dixon W, Chinoy H. A review of accelerometer-derived physical activity in the idiopathic inflammatory myopathies. BMC Rheumatol. 2019;3:41.","journal-title":"BMC Rheumatol"},{"issue":"4","key":"1233_CR62","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.rdc.2025.07.011","volume":"51","author":"M Almackenzie","year":"2025","unstructured":"Almackenzie M, Aggarwal A, Rockette-Wagner B, Aggarwal R. Physical Activity Monitors in Myositis: Bridging the Gap from Bedside to Clinical Trials. Rheum Dis Clin North Am. 2025;51(4):703\u201318.","journal-title":"Rheum Dis Clin North Am"},{"issue":"7","key":"1233_CR63","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.ard.2025.04.024","volume":"84","author":"A Ravelli","year":"2025","unstructured":"Ravelli A, Rosina S, MacMahon JM, Baird T, Rebollo-Gimenez AI, Hinze C, et al. Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society\/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force. Ann Rheum Dis. 2025;84(7):1055\u201367.","journal-title":"Ann Rheum Dis"},{"key":"1233_CR64","doi-asserted-by":"crossref","unstructured":"MacMahon JM, Ravelli A, Rebollo-Gimenez AI, Natoli V, Campone C, Bovis F, et al. Toward a treat-to-target strategy in juvenile dermatomyositis: what are the suitable targets and optimal timing of their achievement? Arthritis Rheumatol. 2025.","DOI":"10.1002\/art.43431"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01233-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01233-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01233-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:01:23Z","timestamp":1786586483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12969-026-01233-4"}},"subtitle":["(Narrative review describing the development, validation, and application of clinimetric outcome measures in juvenile dermatomyositis)"],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1233"],"URL":"https:\/\/doi.org\/10.1186\/s12969-026-01233-4","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"53"}}